Company intelligence / Profile preview

Merck Eprova

Schaffhausen, Schaffhausen, Switzerland

Ownership: Private
Development stage: Other

Overview

Merck Eprova is a longstanding Swiss-based subsidiary of Merck KGaA, specializing in the development and manufacture of high-purity folate derivatives and chiral compounds, supplied as active pharmaceutical ingredients (APIs) and for food/nutrition applications. There is no clinical pipeline as it is a manufacturing and ingredient supply business.

Therapeutic areas: OncologyHematologyNeurologyOther
Modalities: Small moleculeVitamins and derivatives (mainly folates)
Industry: Contract Manufacturing Organization

Partnerships

Supplies ingredients/APIs to major drug and nutrition companies globally

Beyond the preview

Go deeper on Merck Eprova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merck Eprova.

Explore the full profile